Follow
Nico Kraus
Nico Kraus
University Hospital Frankfurt
Verified email at med.uni-frankfurt.de
Title
Cited by
Cited by
Year
Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis
S Torres, C Ortiz, N Bachtler, W Gu, LD Grünewald, N Kraus, ...
Hepatology 77 (4), 1228-1240, 2023
92023
Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1
C Ortiz, S Klein, WH Reul, F Magdaleno, S Gröschl, P Dietrich, ...
Cell Reports 42 (2), 2023
52023
The non-selective Rho-kinase inhibitors Y-27632 and Y-33075 decrease contraction but increase migration in murine and human hepatic stellate cells
N Bachtler, S Torres, C Ortiz, R Schierwagen, O Tyc, C Hieber, ML Berres, ...
Plos one 18 (1), e0270288, 2023
52023
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice
E Dorochow, N Kraus, N Chenaux-Repond, S Pierre, A Kolbinger, ...
International journal of molecular sciences 24 (12), 10351, 2023
22023
New Rat Model of Cholestatic Liver Cirrhosis Developing Acute-on-Chronic-Liver failure
N Kraus, M Moeslein, R Schierwagen, C Ortiz, S Torres, O Tyc, C Hieber, ...
Zeitschrift für Gastroenterologie 60 (01), P 1.14, 2022
12022
New Rat Model of Alcoholic Liver Cirrhosis Developing Acute-on-Chronic-Liver failure
N Kraus, FE Uschner, M Moeslein, R Schierwagen, C Ortiz, S Torres, ...
Zeitschrift für Gastroenterologie 60 (01), P 1.15, 2022
12022
BI-3231, an enzymatic inhibitor of HSD17B13, reduces lipotoxic effects induced by palmitic acid in murine and human hepatocytes
L Alcober-Boquet, N Kraus, LS Huber, R Vutukuri, DC Fuhrmann, ...
American Journal of Physiology-Cell Physiology 326 (3), C880-C892, 2024
2024
The Role of Hypoxia-Inducible Factor 1 Alpha in Acute-on-Chronic Liver Failure
MM Mücke, N El Bali, KM Schwarzkopf, FE Uschner, N Kraus, L Eberle, ...
International Journal of Molecular Sciences 25 (3), 1542, 2024
2024
Higher prevalences and titers of CMV, EBV and HSV1 viremia in patients with acute-on-chronic liver failure derived from the ACLF-I cohort
J Sonnenberg, K Thiyagarajah, E Görgülü, M Glitscher, T Wiedemann, ...
Zeitschrift für Gastroenterologie 62 (01), P5. 20, 2024
2024
ACCELERATION OF AN ADVANCED NASH MODEL BY ACUTE AND TOXIC EFFECTS OF PHENOBARBITAL
N Kraus, M Moeslein, R Schierwagen, W Gu, MJ Brol, FE Uschner, ...
HEPATOLOGY 78, S1065-S1065, 2023
2023
Charakterisierung neuer Tiermodelle des akut-auf-chronischen Leberversagens
FE Uschner, RF Costa, N Kraus, M Moeslein, R Schierwagen, W Gu, ...
Zeitschrift für Gastroenterologie 61 (08), KV087, 2023
2023
Development and characterization of novel rodent ACLF models
FE Uschner, RF Costa, N Kraus, M Möslein, R Schierwagen, W Gu, ...
BDL 250, 4, 2023
2023
Acceleration of an advanced NASH model by acute and toxic effects of Phenobarbital
S Klein, N Kraus, M Moeslein, R Schierwagen, W Gu, MJ Brol, ...
Zeitschrift für Gastroenterologie 61 (01), P1. 23, 2023
2023
Combination of CCL4-induced decompensated cirrhosis with acute polymicrobial peritonitis as an optimized experimental model mimicking extrahepatic organ failures defined in ACLF
R Flores-Costa, A Salvatella, BJ Contreras, M Duran-Güell, M Casulleras, ...
Journal of Hepatology 77, S362, 2022
2022
JANUS KINASE 2 INHIBITION BY PACRITINIB IS A POTENTIAL THERAPEUTIC TARGET FOR LIVER FIBROSIS AND PORTAL HYPERTENSION
ST Nunez, N Bachtler, C Ortiz, N Kraus, R Schierwagen, C Hieber, ...
HEPATOLOGY 74, 822A-823A, 2021
2021
Intercellular crosstalk regulating ARRB2/RARRES1 is involved in transition from fibrosis to cancer
R Schierwagen, P Dietrich, J Heinzen, S Klein, FE Uschner, C Ortiz, O Tyc, ...
bioRxiv, 2021.09. 08.458161, 2021
2021
The system can't perform the operation now. Try again later.
Articles 1–16